
TRDA
Entrada Therapeutics, Inc.NASDAQHealthcare$13.15+5.55%ClosedMarket Cap: $503.4M
As of 2026-04-06
Insider Statistics (Q2 2026)
Purchases
0
Sales
1
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$1.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Apr 02 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | Sell | 2,500 | $12.95 | 119,010 |
| Wed Mar 11 | Dowden Nathan J | officer: President & COO | Sell | 11,894 | $13.05 | 198,588 |
| Wed Mar 11 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | Sell | 5,089 | $13.00 | 132,898 |
| Wed Mar 11 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | Sell | 11,388 | $13.02 | 121,510 |
| Wed Mar 11 | Dowden Nathan J | officer: President & COO | Sell | 3,116 | $13.02 | 210,482 |
| Fri Mar 06 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | Sell | 7,988 | $12.25 | 137,987 |
| Tue Mar 03 | Doshi Dipal | director, officer: CEO | Sell | 139,400 | $0.00 | 555,064 |
| Tue Mar 03 | Doshi Dipal | director, officer: CEO | Sell | 9,869 | $11.66 | 545,195 |
| Tue Mar 03 | Doshi Dipal | director, officer: CEO | Sell | 19,181 | $11.76 | 526,014 |
| Tue Mar 03 | Doshi Dipal | director, officer: CEO | Sell | 208,000 | $11.93 | 208,000 |
| Tue Mar 03 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | Sell | 44,600 | $0.00 | 154,626 |